Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Adjunctive Hydrocortisone Improves Hemodynamics in Critically Ill Patients with Septic Shock: An Observational Study Using Transpulmonary Thermodilution

View through CrossRef
Introduction: Septic shock is associated with high mortality and hemodynamic impairment. The use of corticoids is a common therapeutic tool in critically ill patients. However, data on the mechanisms and prognostic ability of hemodynamic improvement by adjunctive steroids are rare. This study primarily aimed to evaluate short-term effects of hydrocortisone therapy on catecholamine requirement and hemodynamics derived from transpulmonary thermodilution (TPTD) in 30 critically ill patients with septic shock and a 28 days mortality rate of 50%. Methods: Hydrocortisone was administered with an intravenous bolus of 200 mg, followed by a continuous infusion of 200 mg per 24 h. Hemodynamic assessment was performed immediately before as well as 2, 8, 16, and 24 h after the initiation of corticoids. For primary endpoint analysis, we evaluated the impact of hydrocortisone on vasopressor dependency index (VDI) and cardiac power index (CPI). Results: Adjunctive hydrocortisone induced significant decreases of VDI from 0.41 (0.29-0.49) mmHg−1 at baseline to 0.35 (0.25-0.46) after 2 h ( P < .001), 0.24 (0.12-0.35) after 8 h ( P < .001), 0.18 (0.09-0.24) after 16 h ( P < .001) and 0.11 (0.06-0.20) mmHg−1 after 24 h ( P < .001). In parallel, we found an improvement in CPI from 0.63 (0.50-0.83) W/m2 at baseline to 0.68 (0.54-0.85) after 2 h ( P = .208), 0.71 (0.60-0.90) after 8 h ( P = .033), 0.82 (0.6-0.98) after 16 h ( P = .004) and 0.90 (0.67-1.07) W/m2 after 24 h ( P < .001). Our analyses revealed a significant reduction in noradrenaline requirement in parallel with a moderate increase in mean arterial pressure, systemic vascular resistance index, and cardiac index. As a secondary endpoint, our results showed a significant decrease in lung water parameters. Moreover, changes in CPI (ΔCPI) and VDI (ΔVDI) after 24 h of hydrocortisone therapy revealed accurate prognostic ability to predict 28 days mortality (AUC = 0.802 vs 0.769). Conclusion: Adjunctive hydrocortisone leads to a rapid decrease in catecholamine requirement and a substantial circulatory improvement in critically ill patients with septic shock.
Title: Adjunctive Hydrocortisone Improves Hemodynamics in Critically Ill Patients with Septic Shock: An Observational Study Using Transpulmonary Thermodilution
Description:
Introduction: Septic shock is associated with high mortality and hemodynamic impairment.
The use of corticoids is a common therapeutic tool in critically ill patients.
However, data on the mechanisms and prognostic ability of hemodynamic improvement by adjunctive steroids are rare.
This study primarily aimed to evaluate short-term effects of hydrocortisone therapy on catecholamine requirement and hemodynamics derived from transpulmonary thermodilution (TPTD) in 30 critically ill patients with septic shock and a 28 days mortality rate of 50%.
Methods: Hydrocortisone was administered with an intravenous bolus of 200 mg, followed by a continuous infusion of 200 mg per 24 h.
Hemodynamic assessment was performed immediately before as well as 2, 8, 16, and 24 h after the initiation of corticoids.
For primary endpoint analysis, we evaluated the impact of hydrocortisone on vasopressor dependency index (VDI) and cardiac power index (CPI).
Results: Adjunctive hydrocortisone induced significant decreases of VDI from 0.
41 (0.
29-0.
49) mmHg−1 at baseline to 0.
35 (0.
25-0.
46) after 2 h ( P < .
001), 0.
24 (0.
12-0.
35) after 8 h ( P < .
001), 0.
18 (0.
09-0.
24) after 16 h ( P < .
001) and 0.
11 (0.
06-0.
20) mmHg−1 after 24 h ( P < .
001).
In parallel, we found an improvement in CPI from 0.
63 (0.
50-0.
83) W/m2 at baseline to 0.
68 (0.
54-0.
85) after 2 h ( P = .
208), 0.
71 (0.
60-0.
90) after 8 h ( P = .
033), 0.
82 (0.
6-0.
98) after 16 h ( P = .
004) and 0.
90 (0.
67-1.
07) W/m2 after 24 h ( P < .
001).
Our analyses revealed a significant reduction in noradrenaline requirement in parallel with a moderate increase in mean arterial pressure, systemic vascular resistance index, and cardiac index.
As a secondary endpoint, our results showed a significant decrease in lung water parameters.
Moreover, changes in CPI (ΔCPI) and VDI (ΔVDI) after 24 h of hydrocortisone therapy revealed accurate prognostic ability to predict 28 days mortality (AUC = 0.
802 vs 0.
769).
Conclusion: Adjunctive hydrocortisone leads to a rapid decrease in catecholamine requirement and a substantial circulatory improvement in critically ill patients with septic shock.

Related Results

Vitamin C for Sepsis and Septic Shock
Vitamin C for Sepsis and Septic Shock
Background: Sepsis remains a leading cause of death in the critically ill. The combination of thiamine, vitamin C, and hydrocortisone has recently emerged as a potentia...
Predictors of Septic Shock Mortality at a Tertiary Hospital in Ethiopia: A Prospective Observational Study
Predictors of Septic Shock Mortality at a Tertiary Hospital in Ethiopia: A Prospective Observational Study
Abstract Background: Septic shock causes significant mortality, ranging from 30% to 50%, with a slight difference in developing and developed countries. There is insufficie...
Differential gene expression analysis reveals novel genes and pathways in pediatric septic shock patients
Differential gene expression analysis reveals novel genes and pathways in pediatric septic shock patients
Abstract Septic shock is a severe health condition caused by uncontrolled sepsis. Advancements in the high-throughput sequencing techniques have risen the number of...
Kinetics of hydrocortisone sodium phosphate penetration into the human aqueous humor after topical application
Kinetics of hydrocortisone sodium phosphate penetration into the human aqueous humor after topical application
Aim of the study: Hydrocortisone is a soft steroid with low anti-inflammatory properties and a short duration of action, used to manage several ocular conditions. The clinical bene...

Back to Top